Patents by Inventor Jeffrey Braden SPERRY

Jeffrey Braden SPERRY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF ALPHA-1 ANTITRYPSIN
    Publication number: 20240158404
    Abstract: Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).
    Type: Application
    Filed: September 8, 2023
    Publication date: May 16, 2024
    Inventors: Ronald Lee Grey, JR., Emily Elizabeth Allen, Michael J. Boyd, Robert F. Fimognari, JR., Simon Giroux, Michelle Lai-Chen, Ales Medek, Mengqi Li, Christopher David Poff, Daniel Tyler Richter, Tony Z. Scott, Kathleen Paige Sokolowsky, Jeffrey Braden Sperry, Charlene Tsay, Xiaoxu Wang, Mariam Zaky, Chenlong Zhang
  • Crystalline form of 6-[(4R)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]iosoquinoline-1-carbonitrile
    Patent number: 9920043
    Abstract: This invention relates to a novel crystalline form of 6-[(4R)-4-methyl-1,1-dioxido-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile which is useful as a selective androgen receptor modulator (SARM), and to compositions thereof and suitable processes for the preparation thereof.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: March 20, 2018
    Assignee: Pfizer Inc.
    Inventors: Eugene Lvovich Piatnitski Chekler, Roberta Louise Dorow, Jeffrey Braden Sperry
  • CRYSTALLINE FORM OF 6-[(4R)-4-METHYL-1,2-DIOXIDO-1,2,6-THIADIAZINAN-2-YL]ISOQUINOLINE-1-CARBONITRILE
    Publication number: 20170073338
    Abstract: This invention relates to a novel crystalline form of 6-[(4R)-4-methyl-1,1-dioxido-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile which is useful as a selective androgen receptor modulator (SARM), and to compositions thereof and suitable processes for the preparation thereof.
    Type: Application
    Filed: May 1, 2015
    Publication date: March 16, 2017
    Applicant: Pfizer Inc.
    Inventors: Eugene Lvovich Piatnitski CHEKLER, Roberta Louise DOROW, Jeffrey Braden SPERRY